Additionally, reduced E-cadherin expression levels in the diabetic group were linked with invasive disease and possibly poor outcomes in patients with oral squamous cell carcinoma and, therefore, acted as a valuable clinical predictor for tumor behavior, treatment outcomes, and survival [31, 32]. Here, CDH1 is linked to neoplasm.